Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DJ3QK6
|
|||
| Drug Name |
DeTIL-0255
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1 | [1] | |
| Company |
Nurix
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05107739) A Phase 1 Safety and Tolerability Study of DeTIL-0255 in Adults With Advanced Malignancies. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.